The investment marks a significant endorsement for the Oxford University spin-out, which has spent the last two years securing R&D collaborations with industry heavyweights including Corteva Agriscience, Nufarm, Gowan, and Certis Belchim. These partnerships underscore a market-wide shift toward finding new chemical solutions as traditional herbicides struggle against resistant weed populations.
Moa plans to utilize the fresh capital to push its three most advanced programs toward commercialization while expanding its pipeline of early-stage assets. A core focus will remain on the development of 'Moa Amplifiers,' a product category introduced in 2025 that functions by increasing the efficacy of existing treatments, potentially reducing the total volume of chemicals required in field applications.





Comments (0)
No comments yet. Be the first!